INTRODUCTION
The major antigenic protein of int]uenza virus is the haemagglutinin, the predominant protein of two surface proteins projecting from the virus envelope. It comprises two subunits designated HA 1 and HA2. The former contains most, if not all, of the antigenic activity (Brand & Skehel, 1972; Eckert, 1973) .
Over the past 2 years the amino acid sequences of HA 1 s from several different strains of the Hong Kong (H3N2) subtype of influenza virus have been determined. This has been achieved by both protein sequencing (Ward & Dopheide, 1980; Laver et al., 1980) and, more recently, by rapid nucleic acid sequencing methods Min Jou et al., 1980; Sleigh et al., 1981; Verhoeyen et al., 1980) . In addition, specific areas of amino acid changes between different strains have been identified by micro-peptide mapping . Clusters of highly variable amino acids have been identified by comparison of these data ; G. W. Both & M. J. Sleigh, unpublished results) . The determination of the three-dimensional structure of the haemagglutinin of an early Hong Kong strain has shown these clusters to be located on the surface of the HA1 molecule, and has led to the proposition of four distinct antigenic sites .
The present study was aimed at mapping sites of antigenically important amino acid changes on the HA1 molecule in greater detail using a large panel 025) of monoclonal antibodies raised against an early member of the Hong Kong subtype, Northern Territory/60/1968 (NT68).
METHODS

Viruses.
The egg-adapted epidemic strains of the H3N2 subtype were as follows: Northern Territory/60/68 (NT68), Aichi/2/68 (AICHI68), England/878/69 (ENG69), Queensland/ 7/70 (Q70), Hong Kong/107/71 (HK71), England/42/72 (ENG72), Port Chalmers/1/73 (PCH73), Hanover/I/74 (HAN74), Artenay/1/74 (ART74), South Australia/54/74 (SA74), Victoria/3/75 (VIC 75), Victoria/112/76 (Vic76). Recombinant strains were X31 (containing the haemagglutinin gene of AICHI68), MEM/PR8 (containing the haemagglutinin gene of Memphis/102/72), and TEX/BEL (containing the haemagglutinin gene of Texas/I/77). Laboratory mutants of NT68 selected under pressure of fractionated whole serum (Fazekas de St. Groth & Hannoun, 1973) were 375/14, 375/17, 34C, 29C and 30D. Viruses were propagated allantoically and partially purified by adsorption to and elution from chicken erythrocytes. Further purification was carried out in two stages of sucrose density gradient centrifugation. Purified X31, MEM/PR8 and TEX/BEL were kindly supplied by Dr B. Moss.
Virus and antibody titrations. Haemagglutination (HA) titrations were performed in physiological saline in plastic trays by the method of Fazekas de St. Groth & Graham (1954) using 5% chicken erythrocytes. The haemagglutinating unit (HAU) was as defined by Fazekas de St. Groth & Cairns (1952) . The endpoint of the titration was determined by interpolation, reading 7 intermediate degrees of agglutination, giving an accuracy of +7%. Haemagglutination inhibition (HA1) titrations were carried out in 0.25 ml vol. in plastic trays as described by Fazekas de St. Groth et al. (1958) using four agglutinating doses of virus.
Preparation of monoclonal antibodies and measurements of cross-reactivity. Balb/c mice received intraperitoneal injections of 1000 HAU of purified NT68. After a rest period of at least 6 weeks booster injections were given and the spleens removed for fusion 4 days later. The myeloma line used was Sp2/0 (Shulman et al., 1978) . Sp2/0 cells (3 x 107) and spleen cells (5 x 107) were fused using Sendal virus (Kohler & Milstein, 1976) or polyethylene glycol 1500 (Galfre et al., 1977) and seeded over eight 24-well Costar trays containing (per well) 2 ml Iscove's medium (Gibco) + HAT + 20% young calf serum and 5 x 104 mouse peritoneal wash cells. Supernatants of cultures showing healthy growth were tested for anti-haemagglutinin antibody by HA1 tests against NT68. Positive cultures were grown up in bottles, subcloned by limiting dilution, and good yielders were stored in liquid nitrogen. Supernatants from these were tested against representative viruses of other subtypes (A0, A 1 and A2) to eliminate antibodies raised against host components or neuraminidase. Supernatants from [laC]leucine-incorporated samples of the remainder were treated with SDS and mercaptoethanol and subjected to SDS-polyacrylamide (10%) gel electrophoresis to identify antibody chain types. Those supernatants containing complete IgG (heavy and light chains) were concentrated by passage through a protein A-Sepharose column (Pharmacia). These semi-purified concentrates were then used in HAI titrations against the panel of 17 test viruses (including NT68). For any particular antibody, all HAI titrations against the complete panel were performed on the same day using the same erythrocyte preparation. HAI tests were used in preference to RIA (using either whole virus or separated haemagglutinin) since the former involved no chemical modification of virus or antibody, and eliminated the confusing effect of the presence of antibodies directed towards parts of the HA molecule normally inaccessible in the whole virus. HAI tests do not detect antibodies which do not interfere with cell binding. Since such antibodies also appear to lack neutralizing activity (Lubeck & Gerhard, 1981; Breschkin et al., i981) they were considered irrelevant to the present study. The cross-reactive profile of each antibody was obtained by calculating the relative titre against each virus in the panel, compared with that against NT68 (log2 HAI against NT68 --log 2 HAI against virus x). The degree of relatedness between any two antibodies was calculated by methods of numerical taxonomy as described below.
Numerical taxonomy (see Sneath & Sokal, 1973) . The average Euclidean distance between any two antibodies, j and k, was calculated from the formula
where n = number of heterologous viruses used (16), and xu, Xik = difference in log 2 between titres of antibody j against NT68 and virus i, and titres of antibody k against NT68 and virus i respectively.
Thus, the value 2 abs(x~-xLk) is a geometric difference. If abs(xij -Xik ) = 3, there is an eightfold (2 s) difference between antibodies j and k with respect to their interactions with virus i. The value of 1 is taken from the mean to reduce the difference between identical antibodies to zero.
All possible comparisons between the 125 antibodies were performed, and a dissimilarity matrix was constructed from the djk values. The individual antibodies were clustered into families using the method of average linkage clustering.
The average dissimilarity between two clusters J and K, containing tj and t K antibodies respectively, was calculated using the formula 1 __ ~'tj )'TtK ¢'l DjK X ~j= 1 ~k= 1 ~jk tj t K Initially, each individual antibody formed a separate cluster. The value of DjK was calculated (in this case djk ) for each antibody comparison. Antibodies having average dissimilarities less than 0-1 were grouped together in common clusters. The new series of clusters so formed were compared again and this time clusters having values of DjK less than 0.2 were joined. This process was continued until all antibodies formed a single cluster.
RESULTS
Examination of a dendrogram (not shown) constructed by numerical taxonomic analysis of the antibody cross-reactions suggested the existence of ten groups of antibodies containing closely related members, with greater distances separating groups from each other. The mean Euclidean distances between groups are shown in Table 1 . Euclidean distances within groups ranged from 0 to 4.0. Groups containing more than five antibodies were compared by a goodness of fit test to the exponential distribution. All such groups could be fitted to this distribution (P > 0.05). Differences between groups were significant (P < 0.05). Nine individual antibodies did not fit with any of the groups but displayed unique binding 5-5 8-6 8-2 9.8 >11 6
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cross-reactivity patterns of these, and of the ten groups are shown in
Cross-reactivity patterns were studied in the light of the three-dimensional structure of the HA1 molecule of X31 (Fig. 1) , and known amino acid changes to date (Table 3) .
Groups of variable amino acids were identified, which are closely arranged in three-dimensional space and appear to influence the binding of particular groups of antibodies. In each case these areas consisted of a 'core' region and a 'peripheral' region. For each antibody group the core region was defined by those viruses consistently excluded from binding with any member of the antibody group [roman type (not underlined) in Table 2 ]. The core region contained amino acid residues within 2 nm of each other (i.e. consistent with the dimensions of knownantibody binding sites; Amzel & Poljak, 1979) , which were different from those in NT68. Such changes were unique within this virus subset and not shared by any viruses able to bind any member of the antibody group. The peripheral region was defined by those viruses exhibiting variable binding characteristics with different individuals within the antibody group [roman type (underlined) in Table 2 ]. It included residues close to the core region which were changed in these viruses. Such changes could be shared with viruses containing changes in the core region, but not with viruses which were fully reactive with all antibodies in the group. The core and periphery are referred to as a target area. They should not be equated with antibody binding sites. Although likely, this is not proven by the present data. Distances between some specific residues within target areas were kindly measured by Dr I. Wilson on the HA 1 molecule of X31. The target areas are summarized in Table 4 .
The relative proximities of the target areas (Table 4 , Fig. 1 ) agree well with the calculated Euclidean distances between antibody groups affected by them ( Table 1) . Table 2 ) Group 1 This group contains 46 antibodies. Common characteristics are complete reactivity with viruses AICHI68, ENG69, 34C, 375/14 and 29C. Consistently low binding was observed with viruses Q70, ENG72, PCH73 and VIC75. Twenty-four antibodies were fully reactive with both HK71 and 30D. Nine antibodies were reactive with 30D but completely excluded from HK71 and 13 showed the opposite activity.
Characteristics of individual groups (see
The target area of these antibodies should, therefore, comprise a core containing residues with changes confined to Q70, ENG72, PCH73 and VIC75, and a periphery containing additional residues changed in HK71 and 30D.
The only core region fitting these criteria is a line containing residues 129 (Q70), 160 (PCH73), 155 (ENG72, PCH73 and VIC75), 189 (VIC75) and 193 (PCH73 and VIC75) ( Table 3 , Fig. 1 ). The change in Q70 in residue 129 is also shared by HK71. It is thus surprising that some antibodies bind to HK71. This latter virus, however, also has a change in residue 159, from serine to arginine. This is close enough to make contact with the new glutamic acid in position 129 and form a salt bridge. If this occurred, the interfering effect of Fig. 1 . t Position of amino acids in primary sequence of HA1.
the larger, charged, side chain on residue 129 might be removed, and only antibodies binding very closely to residue 159 might be affected. The selective exclusion of either 30D or HK71 indicates that the changes within the target area, brought about by the substitution of the peripheral residues 186 (30D) and 188/198 (HK71) respectively, affect the binding of subsets of the antibody group in different ways.
Group 2
This group contains 16 antibodies. Common characteristics are complete reactivity with A1CHI68, ENG69, 34C, 375/14, 375/17, and 29C. Consistently low binding was observed with HK71, PCH73 and VIC75. Individual antibodies showed variable reactions with Q70, ENG72 and 30D. Reactivity towards these three varied independently. The target area of these antibodies should, therefore, contain changes confined to HK71, PCH73 and VIC75, with a periphery containing additional residues with changes unique to each of Q70, ENG72 and 30D.
These criteria are only satisfied within the amino acid loop from residues 188 to 198. This contains changes at position 188 shared by HK71, PCH73 and VIC75, at 198 shared by HK71 and PCH73, at 193 shared by PCH73 and VIC75, and at 189 unique to VIC75. The periphery could include residues 129, 155 and 186 recognized by antibodies which show reduced binding to Q70, ENG72 and 30D respectively.
Group 3
This group contains 13 antibodies. Common characteristics are low reactivity with PC H73 and VIC75 and complete reactivity with ENG72, 34C, 375/14, 375/17 and 29C. Individual antibodies showed independently variable reactions with AICHI68, ENG69, Q70 and 30D. Antibodies displaying reduced activity with HK71 also failed to bind to Q70.
There are three possible target areas for this group. The first core contains residues 160 (PCH73), 126 and 164 (VIC75); the second contains 193 (PCH73 and VIC75) and 189 (VIC75); the third contains 63 and 78 (both changed in PCH73 and VIC75). Consideration of peripheral effects makes it very difficult to place the target area with any degree of certainty, as it must include residues 182 (AICHI68), 63/81 (ENG69) and 186/220 (30D) which are widely separated on a single HA 1 molecule. The most likely target area appears to be the first (area 1) for reasons discussed below. It is possible that residue 220 on one HA1 molecule could influence binding to area 1 on an adjacent molecule. This residue is in the interface region, very close to residue 205 on the adjoining molecule, which places it close to the loop containing residues 160 to 164 (see Fig. 1 ). Residue 182 is also very close to residue 220 and may also influence binding of antibodies in this area.
Residues 63 and 81 (changed in ENG69) are rather far away from area 1. The changes which take place in ENG69, however, remove one carbohydrate attachment site and replace it with another (which may or may not be utilized) . The effects of such a change might be more far-reaching than just the substitution of one amino acid with another, and in this respect might affect the area around residue 126.
The remaining viruses showing variable activity, Q70 and HK71, have changes at residues 129 and 159, which also might be close enough to affect area 1. Lack of binding to HK71 was always accompanied by lack of binding to Q70, but the reverse was not true. As discussed above in group 1, the simultaneous changes of residues 129 and 159 (HK71) may result in a smaller disturbance to antibody binding than a change in 129 alone (Q70). Any antibodies recognizing the double change would, therefore, be very likely to recognize the single change, but the reverse would not necessarily apply.
This group of antibodies binds to NT68 with significantly lower affinity than any of the other groups (P. A. Underwood, unpublished observations). Such antibodies might be influenced by changes at greater distances in the HAl molecules than would affect the binding of those with higher affinity. Also, this area may be uniquely affected by changes in carbohydrate position or orientation. The orientation of the carbohydrate attached at position 165 may be altered by changes in residue 164, or in the interface region.
The change in residue 126 in VIC75 to asparagine creates a new carbohydrate attachment site, which may or may not be utilized.
Group 4
This group contains only three antibodies very closely related to each other. They were very unreactive with Q70, HK71, and PCH73 and showed moderately reduced binding with VIC75. They were reactive with the other eight viruses.
There are two possible target areas for this group. The first comprises a core including residues 129 (QT0), 198+/-188 (HKT1 and PCH) and possibly also 160 (PCH). Peripheral effects could be due to changes in one or both of 189 or 193 (VIC75). The core of the second area could include the loop containing residues 129 and 132 (Q70 and HK71) and the loop above it containing residue 160 (PCH) with a peripheral effect of residue 126 (VIC75).
Group 5
This group contains three antibodies. All showed reduced reactivity with Q70, HK71, PCH73 and VIC75, the effect being greater with the last three. All were completely reactive with the remaining viruses.
There are two possible target areas for this group both similar to group 4. The major differences between these two groups were observed in their reactivities with the four unsequenced viruses. In this group the first target area could contain key residues in the 188 to 198 loop at positions 188 (HK71, PCH73 and VIC75), 189 (VIC75), 193 (PCH73 and VIC75) and 198 (HK71 and PCH73), with a residue of lesser importance in position 129 (Q70).
The second target area could comprise the two loops containing residues 126 (VIC 75), 129 (Q70), 132 (HK71) and 159 (HK71), 160 (PCH73). Residues 129 and 159 may be of lesser importance than the others. The most closely related group to both groups 4 and 5 is group 3 (see Table 1 ). This would slightly favour the second target area in both cases, involving the residues on the 126 to 132 loop and residue 160. The next most closely related groups are groups 7 and 6 respectively which also recognize changes in this region (see below).
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Group 6
This group contains 16 antibodies. All members showed reduced activity with VIC75. Subgroups showed different and independent degrees of reactivity with Q70, HK71 and PCH73. All were fully reactive with the remaining eight viruses.
The unique changes in VIC75 are in residues 126, 137, 189, 164 and 174. Of these, 137 and 174 are far removed from any changes in Q70 (Fig. 1) . With respect to residue 189 it is unlikely that antibodies excluded from binding to HK71, due to the changes in residues 188 and 198, would show independence from the same changes in PCH73.
The core of the target area of these antibodies is, therefore, most likely to contain residues 126 and/or 164. The periphery is likely to contain residues 129 (Q70), 132 (HK71) and 160 (PCH73). 129 and 132 are considerably closer in space to residue 126 than 164. The latter residue may cause a change in orientation of the carbohydrate attached at position 165, which might in turn influence antibodies binding in the area of residue 126, as well as a change in residue 126 itself. It should, therefore, probably be more correctly placed in the periphery of the target area.
Group 7
This group contains eight antibodies which showed consistently low reactivity with HK71. Half of them also showed reduced reactivity with Q70. All were reactive with the remaining 10 viruses. This group of antibodies probably recognizes the unique change in residue 132 in HK71. Some of the antibodies might be affected by the change in residue 129 in Q70.
Group 8
This group contains five antibodies. They were all very unreactive with viruses Q70, VIC75, 29C and 30D. All were reactive with AICHI68, ENG69, ENG72, and the remaining laboratory mutants. Individual antibodies varied independently in their reactions with PCH73 and HK 71.
The target area of these antibodies probably includes residues 226 (Q70 and 29C), 186 (30D) and 137 (VIC75). Residue 220 (30D) is also close to 226 and 186 and might influence binding in this area. The periphery could include residues 188 (HK71 and PCH73), 189 (VIC75) and 193 (PCH73 and VIC75).
Group 9
This group contains three antibodies which have the same reactivities as group 8 except that they were very unreactive with 375/14. This mutant was originally thought to be identical to 34C Moss et al., 1980) . Recent tryptic thermolytic peptide mapping, however (B. A. Moss, personal communication), has indicated that 375/14 may have a change in residue 186 from serine to threonine. The effect of this change would be smaller than the substitution to isoleucine in 30D and, therefore, antibodies which failed to bind to 30D might still bind to 375/14 (e.g. groups I, 2 and 8). The target area of this group, therefore, is likely to be the same as that of group 7, the antibodies being more discriminating towards the particular residue in position 186.
Group 10
This group comprises three antibodies. They are very distantly related to all the other groups and appear to be influenced solely by changes in residue 144. They showed reduced reactivity with AICHI68, Q70, 34C and 375/14, all of which have glycine in position 144. They showed significantly increased reactivity with the remaining viruses, all of which contain aspartic acid in this position. Since our laboratory strain of NT68 possesses a mixture of these amino acids in position 144, this result would be expected of antibodies raised against the Asp form. 
Unclassified antibodies
Nine antibodies appeared to belong to no particular group according to their cross-reactions, which are shown in Table 2 . No attempt is made to assign their target areas, but their closest affiliations to particular groups are shown in the table.
Reactivity patterns with other viruses of known HA1 sequence
In order to test the validity of the proposed binding sites of the different antibody families, representatives of each subgroup were titrated against three viruses whose HA1 nucleotide sequence became available at a later date.
These were as follows. (i) The X31 recombinant of AICHI68 was used to check which of the reported amino acid changes (residues 158 plus 78 or 182) was present in our AICHI68. The X31 recombinant contained the change at residue 182, but no changes at residues 158 or 78 (G. W. Both, unpublished observations on nucleotide sequence). (ii) A recombinant of MEM72-MEM/PR8. The only reported differences between the HA1 amino acid sequence of this virus and ENG72 were the Asn--,Asp change in residue 188 and the Leu--,Gln change at 226 of MEM/PR8 and Arg~Gly at 208 of ENG72. They share the change at position 155. (iii) TEX77. This virus contains many changes from the sequence of NT68 in HA1 in all the proposed target areas. It was included for interest to see how many, if any, of the antibodies could combine with it, after such extensive evolution.
Titration values are compared with NT68 in Table 5 . Results for AICHI68 and ENG72 are also included for comparison with X31 and MEM/PR8 respectively.
X31
The only differences observed between NT68 and X31 were in group 10 due to the glycine form of residue 144, and in group 3. This is in complete agreement with the results for AICHI68 and supports the supposition that the change in AICHI68 was at residue 182. [In a previous report , it was thought that the HA sequence of the strain of AICHI68 used in antibody titrations was the same as that described by Ward & Dopheide (1980) , and that the change they reported in residue 158 was of minor antigenic importance.
Since it now appears that residue 158 is unchanged in our virus sample, the importance of this residue, which is changed in TEX77 and BK79, remains unknown.] X31 shares with AICHI68 the increased binding to antibody 78, lending further weight to the identity of these two viruses.
MEM/PR8
Antibody 120 from group 2 reacted with ENG72 but not with MEM/PR8, indicating recognition of the change in residue 188 in the latter (see Table 4 ). Antibody 95, however, p.A. UNDERWOOD showed reduced binding to both viruses (although the effect was greater with MEM/PR8) probably also recognizing the common change in residue 155.
Members of groups 8 and 9 bound to ENG72 but not to MEM/PR8. This difference is probably due to the change in MEM/PR8 at position 226 which it shares with Q70 and 29C. Where binding was also reduced to HK71 and PCH73 (antibody 101), the change at position 188 was probably also recognized (Table 4) .
Members of groups 4 and 5 were reactive with both viruses, indicating that the change in residue 188 in MEM/PR8 was not recognized. This does not enable elimination of either target area for these two groups, since it may be the simultaneous change in residues 188 and 198 (which are close enough to interac0, which is recognized (Table 4 ).
The remaining antibodies tested behaved as expected, with similar reactivities for ENG72 and MEM/PR8, except for antibody 78 which discriminated between them, implicating either residue 188, 226 or 208 in its target area.
TEX77
This virus showed an interesting feature in that it did not bind to the representative of group 10. This virus has the Asp form in residue 144, but it has so many other changes close by ( Table 3 ) that these probably prevented antibody binding. Antibody 78 was the only antibody of 60 tested which showed any binding to TEX77.
Reaetivities of the unsequeneed viruses HAN74, ART74, SA 74 and VIC76
These were included in the virus panel for cross-reactivity tests, in order to maximize the sensitivity of the antibody grouping. Little can be said about their antibody-binding characteristics without sequence data. Their reactivity patterns, however, have several interesting characteristics and some predictions about the locations of amino acid changes can be made (see Tables 2 and 4). HAN74 probably has changes in target areas defined by antibody groups 1, 2 and 9; ART74 in areas defined by groups 1, 2, and 4 to 8; SA74 in areas defined by groups 1, 2, 3, and 6 to 9; VIC76 in areas defined by groups 1 to 8. Members of antibody group 10 showed increased reactivity with all four viruses, indicating the Asp form of residue 144, as would be expected from their dates of isolation. Antibodies 75, 77 and 91 were of interest in that they distinguished between VIC75 and VIC76. Knowledge of the HA 1 amino acid sequences for these viruses would probably improve the placement of target areas of antibody groups 3, 4 and 5.
DISCUSSION
The results of the present study have been used in an attempt to identify groups of variable amino acids in the haemagglutinin of influenza NT68 which affect the binding of 125 monoclonal antibodies, raised to this molecule. Each group contained a core region including residues which affected the binding of a number of antibodies, and a periphery containing residues which influenced the binding of particular antibodies within this number. These characteristics agree with the description of antigenic determinants of myoglobin suggested by East et al. (1980) . Strong supporting evidence was found for the identities of antigenic 'sites' A and B named by Wiley et al. (1981) and possibly also part of 'site' D. In addition, intermediate areas on both sites of the HA 1 molecule (see Fig. 1 ) also appear to influence antibody binding. Rather than defining separate discrete antigenic sites A, B, etc., it is probably more realistic to define a continuous area of amino acids surrounding the proposed cell-receptor pocket which influence antibody binding. The actual antibody binding sites may be discrete or overlapping within this area (or even remote from it).
This is in agreement with the findings of other workers. (Lubeck & Gerhard, 1981) suggested that two of them recognized antigenic sites which were in close proximity on the HA molecule. A third was a little further away and the fourth was remote from the other three. The authors suggested that these sites represented specific locations within a large contiguous antigenic area. Breschkin et al. (1981) have produced similar results using competitive binding assays between a small number of monoclonal antibodies raised to the HA of a Hong Kong recombinant virus [A/Memphis/102/72(H3)-A/Bel/42(N 1)l. None of the antibodies described in this report was apparently affected by changes in the proposed antigenic 'site' C . The fact that amino acid changes accumulate in this area in TEX77 and BK79 suggested it may have antigenic importance. Immunological support for the antigenic identity of 'site' C is derived from a virus variant with a change in residue 53, selected under pressure of a mouse monoclonal antibody (Webster & Laver 1980) . It was not conclusively demonstrated that this was the only changed amino acid, since some insoluble peptides were not analysed.
Changes in 'site' C, however, always occurred concomitantly with changes in other areas (see Table 3 ). Thus, their effect, if any, may be masked, or may magnify effects in other areas. All that can be said is that changes in 'site' C alone, which would alter the binding of antibodies to only ENG72, PCH73 and VIC75 in the present virus panel, were not recognized by any of the 125 antibodies used in the present study.
Only a few of the changes in proposed 'site' D app'eared to affect antibody binding (164, 182, 220 and 226) . Many of the others are in the interface region between adjacent molecules and it is difficult to assess their effect, if any, on antigenic regions on the outer surface. The change at position 201, unique to 34C and 375/14 , was not recognized by any of the antibodies.
The change in residue 78 observed in some viruses was previously correlated with adsorptive mutation . With the additional information of many more sequences, this correlation disappears. Since amino acid changes take place all around the rim of the proposed cell-receptor pocket, there are many candidates for influencing interactions between the haemagglutinin and the cellular receptor.
Most of the monoclonal antibodies described here displayed both common and specific binding characteristics, depending on which viruses were included for comparison. Thus, if an antibody bound to a site on virus A which was influenced by an amino acid which changed in virus B, it would be excluded from binding to virus B and would be scored as specific for A. With other viruses not possessing a change in that particular amino acid, the antibody would be scored as common. The only antibody which displayed general common binding was No. 40 (see Table 2 ).
Finer definition of the amino acids on the HA 1 molecule which influence antibody binding can be achieved when more sequence data are available for other virus strains. The relationship between these target areas and antibody binding sites can be derived from a combination of the following approaches. (i) Artificial synthesis of small peptides proposed as binding sites, as Sutcliffe et al. (1980) have described for Moloney leukaemia virus and testing for binding of antibodies.
(ii) Isolation of many antigenic mutants under pressure of monoclonal antibodies and mapping the positions of amino acid substitution as described by Webster & Laver (1980) . (iii) Assays of competitive binding between monoclonal antibodies (particularly Fab fragments) as described by Lubeck & Gerhard (1981) and Breschkin et al. (1981) .
It was hoped that a panel of monoclonal antibodies of the order used here would reflect the distribution of antibodies produced by the Balb/c mouse in vivo. It does not necessarily reflect the human distribution. The number of antibodies affected by changes in different groups of HA amino acids was by no means equal. Only three antibodies appeared to be influenced by changes in 'site' A. This site is thought to be an important region of antigenic change (Webster & Laver, 1980) and is the location of the major difference between AICHI68 (the closest representative of the earliest strains of the Hong Kong subtype) and ENG69. One would expect a larger number of antibodies to be affected by changes in this site, unless the immune system of the mouse has difficulty in recognizing this particular area. As mentioned above, however, our NT68 comprises a mixture of Asp and Gly at position 144 of the HA1 molecule and is not, therefore, a true representative of the earliest strain of the subtype. The three antibodies affected by this area bound very well to all the viruses with Asp at position 144, until TEX77. If such antibodies formed a major proportion of the antiserum, future mutants over the years following ENG69 would have been readily neutralized. It seems more likely that different areas of the molecule are important immunologically at different stages of evolution of the virus. This could be governed by the extent of immune pressure on the different antibody binding sites (i.e. the way each site is presented to the immune system), stability of the mutant haemagglutinin, and growth characteristics of the resulting mutants. Thus, initially, the change in residue 144 in 'site' A was important. The fact that this change occurred in the laboratory spontaneously in NT68 without any immune pressure indicates that it is stable and has good growth characteristics. It is not surprising that such a change would have been selected first. In the field, presumably a large number of human antibodies were directed to the Gly form of residue 144, allowing the Asp form to take over.
Consideration of Table 3 shows that over the next few years, amino acids in the region of 'site' A changed little, if at all, the main emphasis of change being in 'site ' B up until 1975 , with some changes in adjacent regions. The emphasis then seemed to switch back to areas close to 'site' A with the mutations producing TEX77. BK79 showed additional changes in most areas, indicating fairly uniform immune pressure over the whole antigenic region. HK71 and Q70 were interesting in that they seem to have acquired a number of amino acid changes which place them ahead of their time. Gerhard et al. (1981) have shown that uneven antigenic drift has also occurred among the antigenic sites of the HA of another influenza subtype (HON1) although they derive their conclusions in a different way. Work is in progress to produce panels of monoclonal antibodies against other members of the Hong Kong subtype in order to test the hypothesis that the position of emphasis of antibody pressure within the antigenic area of the haemagglutinin changes as the virus evolves.
I am very grateful to Dr D. Wiley for valuable discussions and access to unpublished stereo drawings of the HA1 molecule of AICHI68, and to Dr I. Wilson for measurements of distances between specific amino acid residues. I am also grateful to Professor S. Fazekas de St. Groth for the suggestion of using numerical methods for antibody classification, and to Dr A. J. Underwood for helpful discussions on statistical methods. I thank Drs B. Moss, M. Sleigh and G. Both for access to sequence data prior to publications and for critically reading the manuscript, Mrs R McDonald, H. Stobbie and N. Villa for expert technical assistance, and Mrs J. Drummond for endless patience in preparing the typescript.
